Results for tag: "Generic Oncology Drug"

The Generic Oncology Drug market is a subset of the larger Generic Drug market. Generic Drugs are copies of brand-name drugs that have the same active ingredients, dosage form, strength, route of administration, safety, efficacy, and intended use as the original drug. Generic Oncology Drugs are used to treat cancer and are typically much less expensive than their brand-name counterparts. Generic Oncology Drugs are typically available in oral, injectable, and topical forms. Generic Oncology Drugs are subject to the same regulatory standards as brand-name drugs, and must meet the same safety and efficacy requirements. Generic Oncology Drugs are typically available in the same dosage forms and strengths as their brand-name counterparts. Some companies in the Generic Oncology Drug market include Mylan, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more